CRVS icon

Corvus Pharmaceuticals

52 hedge funds and large institutions have $28M invested in Corvus Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 10 closing their positions.

Holders
52
Holders Change
Holders Change %
0%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
15
Reduced
11
Closed
10
Calls
$114K
Puts
$113K
Net Calls
+$1K
Net Calls Change
+$7K
Name Holding Trade Value Shares
Change
Shares
Change %
IA
51
IFP Advisors
Florida
$35
PA
52
Parallel Advisors
California
$29
AG
53
Artal Group
Luxembourg
-$1.15M -500,000 Closed
CA
54
CHI Advisors
New York
-$458K -200,000 Closed
CIC
55
Cornercap Investment Counsel
Georgia
-$223K -97,248 Closed
Acadian Asset Management
56
Acadian Asset Management
Massachusetts
-$132K -58,069 Closed
Jane Street
57
Jane Street
New York
-$80.4K -35,118 Closed
Squarepoint
58
Squarepoint
New York
-$39.1K -17,082 Closed
CSS
59
Cubist Systematic Strategies
Connecticut
-$35.6K -15,552 Closed
TAM
60
Tucker Asset Management
Colorado
-$29.5K -12,871 Closed
DCM
61
Difesa Capital Management
New York
-$22.9K -10,000 Closed
NC
62
NewSquare Capital
Pennsylvania
-$504 -220 Closed